WiseGuyReports.Com Publish a New Market Research Report On –“ Acute Conjunctivitis Treatment 2020 Global Market Outlook,Research,Trends And Forecast To 2023”.
Acute Conjunctivitis Treatment Market 2020
Description: –
Conjunctivitis, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Conjunctivitis can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Symptoms includes tearing, itching and redness of the eyes. It can also lead to discharge or crusting around the eyes. It’s important to stop wearing contact lenses whilst affected by conjunctivitis. Conjunctivitis often resolves on its own, but treatment can speed up the recovery process. Allergic conjunctivitis can be treated with antihistamines. Bacterial conjunctivitis can be treated with antibiotic eye drops.
Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2753886-global-acute-conjunctivitis-treatment-market-market-estimation-dynamics-regional-share
For more information or any query mail at sales@wiseguyreports.com
Major Key Players Included are:-
Some of the players in global acute conjunctivitis treatment market are Pfizer, Inc. (U.S), Allergan Inc. (Ireland), Boehringer Ingelheim GmbH (Germany), CIBA Vision Ophthalmics (U.S), Sanofi (France), Novartis AG (Switzerland), Bausch & Lomb Inc. (Valeant) (Canada), Merck & Co., Inc. (U.S), and Santen Pharmaceuticals Co. Ltd.(Japan)
Acute conjunctivitis treatment market is because of increasing aging of the population, increase in ophthalmic diseases prevalence rate, rise in investments for the development of new products, growing conscious towards health, funded eye check-up campaigns by governments of different countries are driving the growth of acute conjunctivitis treatment market. Moreover, increasing awareness about various eye infections and rise in blindness prevalence among geriatric population boosting the market growth of acute conjunctivitis treatment. However, due to the stringent regulations in drugs developmental process and side effects associated with the various antibiotics would hamper the adoption of eye infection pharmaceutical treatment, in turn, hinder the market growth.
Acute conjunctivitis treatment market is segmented on the basis of type, dosage form, drug class, distribution channel, and geography
Based on the type, acute conjunctivitis treatment market is segmented as:
Viral Conjunctivitis
Bacterial Conjunctivitis
Allergic Conjunctivitis
Conjunctivitis Caused by Irritants
Based on dosage form, acute conjunctivitis treatment market is segmented as:
Gels and Cream
Eye drops
Tablets and Capsules
Based on the drug class, acute conjunctivitis treatment market is segmented as:
Antihistamines
Antibiotic
Mast cell stabilizers
Anti-inflammatory drugs
Others
Based on distribution channel, acute conjunctivitis treatment market is segmented as:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
As per the clinical study conducted by scientists Neal P. Barney and Amir A. Azari in 2013, which was published in Journal of American Medical Association (JAMA), states that bacterial conjunctivitis accounts for about 50% of conjunctivitis cases in U.S. and also estimated that the bacterial conjunctivitis incidence rate was anticipated as 135 in 10,000.Top pharma companies are dominating the market owing to different factors like sale, strong global presence, and efficient distribution network, R&D investments, products of superior quality, and strong brand image. In 2016, Irish based pharma company Shire’s Xiidra received U.S.FDA approval which is used to treat dry-eye. In 2015, Bausch & Lomb Inc. acquired Doctor’s Allergy Formula in order to expand its ophthalmic product portfolio,
On the basis of geographical regions, acute conjunctivitis market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is dominating global acute conjunctivitis market owing to few factors like rising more number of approvals by FDA, various strong strategies by pharma companies, rise in R&D investments. The European market is the second largest market for acute conjunctivitis treatment. Increase in prevalence and growing awareness of conjunctivitis and its treatments are leading the growth of Asia Pacific acute conjunctivitis treatment market. The Middle East and Africa acute conjunctivitis treatment market is expected to have limited growth because of lack of traditional healthcare practices and slow adoption of new products and therapies.
Enquiry About Report @ https://www.wiseguyreports.com/enquiry/2753886-global-acute-conjunctivitis-treatment-market-market-estimation-dynamics-regional-share
Table of Contents – Major Key Points
- Executive Summary
- Global Acute Conjunctivitis Treatment Market Introduction
- Global Acute Conjunctivitis Treatment Market Dynamics
- Global Acute Conjunctivitis Treatment Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
- Global Acute Conjunctivitis Treatment Market, By Drug Class, 2012 – 2016 and Forecast, 2017 – 2023
- Global Acute Conjunctivitis Treatment Market Forecast, By Type, 2012 – 2016 and Forecast, 2017 – 2023
- Global Acute Conjunctivitis Treatment Market Forecast, By Dosage Form, 2012 – 2016 and Forecast, 2017 – 2023
Continued….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
